Bio-Rad’s $24m Trial Victory Over 10X Will Stand, Judge Says

July 9, 2019, 8:07 PM

10X Genomics failed in its bid to overturn a jury verdict that it infringe patents for devices that amplify genetic material so it can be analyzed.

  • Patents are owned by University of Chicago and licensed to Bio-Rad
  • 10X had asked the judge to toss the verdict, order a new trial or at least lower the damage award
  • Jury verdict was “supported by substantial evidence,” said District Judge Richard Andrews in Wilmington, Del.

The case is Bio-Rad Laboratories, Inc. v. 10X Genomics Inc., D. Del., No. 1:15-cv-00152, order 7/9/19.

©2019 Bloomberg L.P. All rights reserved. Used with permission

To read the full article log in. To learn more about a subscription click here.